Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase I study of vandetanib and metronomic chemotherapy in advanced breast cancer

Mayer EL, Isakoff SJ, Hannagan K, Savoie J, Beckman J, Klement G, Gelman R, Winer EP, Burstein HJ. A phase I study of vandetanib and metronomic chemotherapy in advanced breast cancer. Proceedings of the 2009 Dana-Farber Harvard Cancer Center Breast Cancer Symposium. 2009.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.